Trade Summary

1 week ago, Vakiener Victoria, serving as Dir at Arrowhead Pharmaceuticals, Inc. (ARWR), sold 10,040 shares at $67.68 per share, for a total transaction value of $679,491.00. Following this transaction, Vakiener Victoria now holds 35,723 shares of ARWR.

This sale represents a 22.00% decrease in Vakiener Victoria's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, December 19, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, December 23, 2025, 4 days after the trade was made.

Arrowhead Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.